Quad Regimen for High-Risk Myeloma Produces High Rates of Durable MRD Negativity
Two-thirds of transplant-eligible patients met endpoint with isatuximab/KRd
Nordrhein Westfalen Charles Bankhead Katjac Weisel Winship Cancer Institute In Atlanta German Multiple Myeloma Group International Staging System
Source: medpagetoday.com